KNSA
Kiniksa Pharmaceuticals International, plc Class AstockNASDAQ
Market OpenNov 19, 2026 3:47:08 PM EST
93.74USD-1.378%(-1.31)307,717
Pre-marketNov 19, 2026 8:40:30 AM EST
95.30USD+0.263%(+0.25)
KNSA Financials
In Q3 FY 2026 (ended ), Kiniksa Pharmaceuticals International, plc Class A (KNSA) reported revenue of $285.97M, net income of $47.35M, operating cash flow of $47.55M, and assets of $983.24M (filed ).
Loading business breakdowns…